(Abstracted from Am J Obstet Gynecol 2019;220:185.e1–185.e10)
Surgical adverse events (AEs) following urogynecological surgery are common. The incidence of any AEs in surgical studies ranges from 30% to 76%, and serious AEs range from 3% to 17%.
Division of Urogynecology, Department of Obstetrics-Gynecology (G.C.D.) and Department of Family and Community Medicine (A.L.S.), University of New Mexico, Albuquerque, NM; Department of Obstetrics-Gynecology, Duke University, Durham, NC (J.E.J., C.L.A.); Department of Obstetrics-Gynecology, Brown University, Providence, RI (V.S.); Department of Obstetrics-Gynecology, University of Pennsylvania, Philadelphia, PA (U.U.A.); Department of Obstetrics-Gynecology, University of Alabama, Birmingham, AL (A.B.); Department of Obstetrics-Gynecology, Bellflower Medical Center, Bellflower, CA (S.J.-W.); Division of Urology, University of Pittsburgh, Pittsburgh, PA (C.J.C.); Division of Statistical and Data Sciences, RTI International, Research Triangle Park, NC (C.M.B.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD (D.M.); and Dell Medical School, Department of Women’s Health, University of Texas at Austin, Austin, TX (R.G.R.)